76176-87-9 Usage
Uses
Used in Pharmaceutical Industry:
ThioMorpholine-1-oxide HCl is used as a reactive intermediate for the synthesis of various organic compounds, contributing to the development of new drugs. Its unique structure allows for the creation of a diverse range of pharmaceutical agents, enhancing the therapeutic options available.
Used in Agricultural Industry:
In the agricultural sector, ThioMorpholine-1-oxide HCl is utilized as a building block in the synthesis of pesticides, providing an essential component for the development of effective and targeted crop protection solutions.
Used in Polymer Production:
ThioMorpholine-1-oxide HCl is used as a stabilizer and inhibitor in the production of polymers, ensuring the quality and longevity of the final polymer products by preventing unwanted reactions during the manufacturing process.
Used in Organic Chemistry:
As a reagent in organic chemistry reactions, ThioMorpholine-1-oxide HCl facilitates a variety of transformations and processes, enabling chemists to explore new synthetic pathways and develop innovative compounds.
Used in Heterocyclic Compound Synthesis:
ThioMorpholine-1-oxide HCl is used as a key building block in the synthesis of heterocyclic compounds, which are important in various fields such as pharmaceuticals, agrochemicals, and materials science due to their diverse and often biologically active properties.
Check Digit Verification of cas no
The CAS Registry Mumber 76176-87-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,1,7 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 76176-87:
(7*7)+(6*6)+(5*1)+(4*7)+(3*6)+(2*8)+(1*7)=159
159 % 10 = 9
So 76176-87-9 is a valid CAS Registry Number.
76176-87-9Relevant academic research and scientific papers
Heterobicyclic thiophene compounds and methods of use
-
Page/Page column 59-60, (2008/06/13)
Compounds of Formula I and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula I and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
